Status: Not yet recruiting
Incidence of Bleeding, Thrombosis and Transfusion Requirements in ICU Patients With COVID-19 Supported With Veno-venous Extracorporeal Membrane Oxygenation
The investigators aim to assess the risk of bleeding and thrombo-embolic complications as well as benefit and harm of blood product transfusion and anticoagulation therapy in adult ICU patients with COVID-19 supported with V-V ECMO
Participants needed: 50
Trial details
Biological sex: AllType: ObservationalSponsor: Rigshospitalet, DenmarkUpdated: Jan 29, 2026Locations: 1Duration: 90 Days
Eligibility criteria
Adults [+2]